• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调整白喉-破伤风-百日咳疫苗免疫程序对临床实践中百日咳的潜在影响

[Potential impact of adjusting immunization procedure for diphtheria-tetanus-pertussis vaccine on pertussis in clinical practice].

作者信息

Hu Ya-Hong, Yao Kai-Hu

机构信息

National Center for Children's Medicine/Beijing Children's Hospital, Capital Medical University/Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute/National Clinical Research Center for Respiratory Diseases/National Clinical Surveillance Center for Pediatric Infectious Diseases and Allergic Disorders/National Key Discipline of Pediatrics/Key Laboratory of Major Diseases in Children, Ministry of Education/Beijing Key Laboratory of Pediatric Respiratory Infectious Diseases, Beijing 100045, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):786-791. doi: 10.7499/j.issn.1008-8830.2501077.

DOI:10.7499/j.issn.1008-8830.2501077
PMID:40695509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12291569/
Abstract

In recent years, the incidence rate of pertussis in China has been steadily increasing, presenting an increasingly severe challenge for disease prevention and control. To strengthen the immune barrier in the population and effectively curb the spread of pertussis, National Disease Control and Prevention Administration of China and other relevant authorities optimized the immunization procedure for diphtheria-tetanus-pertussis vaccine, with the new procedure implemented in 2025. This adjustment includes three key measures: advancing the initial dose of the vaccine from 3 months to 2 months of age, extending the interval between primary immunization doses from 1 month to 2 months, and adding an extra dose of acellular diphtheria-tetanus-pertussis vaccine at 6 years of age. This article discusses potential changes in the epidemiology and clinical manifestations of pertussis following such adjustments for immunization procedure, and awareness of these changes will facilitate the accurate identification of pertussis cases, which is crucial for evaluating the impact of these adjustments and further optimizing immunization strategies.

摘要

近年来,我国百日咳发病率呈稳步上升趋势,给疾病防控带来了日益严峻的挑战。为强化人群免疫屏障,有效遏制百日咳传播,国家疾病预防控制局等相关部门优化了白喉-破伤风-百日咳疫苗的免疫程序,并于2025年实施新程序。此次调整包括三项关键措施:将疫苗首剂接种月龄从3个月提前至2个月,将基础免疫剂次间隔从1个月延长至2个月,以及在6岁时增加一剂无细胞白喉-破伤风-百日咳疫苗。本文探讨了免疫程序调整后百日咳流行病学及临床表现可能发生的变化,认识这些变化将有助于准确识别百日咳病例,这对于评估这些调整的影响及进一步优化免疫策略至关重要。

相似文献

1
[Potential impact of adjusting immunization procedure for diphtheria-tetanus-pertussis vaccine on pertussis in clinical practice].调整白喉-破伤风-百日咳疫苗免疫程序对临床实践中百日咳的潜在影响
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):786-791. doi: 10.7499/j.issn.1008-8830.2501077.
2
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)联合疫苗与分别接种白喉、破伤风、百日咳、乙型肝炎疫苗和HIB疫苗用于白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)的一级预防。
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD005530. doi: 10.1002/14651858.CD005530.pub3.
3
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)联合疫苗与分别接种白喉、破伤风、百日咳、乙型肝炎疫苗和HIB疫苗用于白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)的一级预防。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD005530. doi: 10.1002/14651858.CD005530.pub2.
4
Non-specific immunological effects of selected routine childhood immunisations: systematic review.特定常规儿童免疫接种的非特异性免疫效应:系统评价
BMJ. 2016 Oct 13;355:i5225. doi: 10.1136/bmj.i5225.
5
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial.孕期接种百日咳疫苗对冈比亚婴儿无细胞或全细胞百日咳疫苗免疫原性的影响(GaPS):一项单中心、随机、对照、双盲4期试验。
Lancet Infect Dis. 2025 Mar 25. doi: 10.1016/S1473-3099(25)00072-6.
6
Acellular vaccines for preventing whooping cough in children.用于预防儿童百日咳的无细胞疫苗。
Cochrane Database Syst Rev. 2014 Sep 17;2014(9):CD001478. doi: 10.1002/14651858.CD001478.pub6.
7
Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccines.婴儿全细胞和无细胞百日咳疫苗接种对同时接种的疫苗的免疫影响。
J Infect. 2025 Jul;91(1):106515. doi: 10.1016/j.jinf.2025.106515. Epub 2025 May 23.
8
Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.卡介苗、百白破疫苗和含麻疹疫苗与儿童死亡率的关联:系统评价
BMJ. 2016 Oct 13;355:i5170. doi: 10.1136/bmj.i5170.
9
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.含基因解毒百日咳毒素的无细胞百日咳疫苗对感染和未感染艾滋病毒的孕妇及其新生儿的安全性和免疫原性(WoMANPOWER):乌干达的一项随机对照试验
Lancet Glob Health. 2025 Jan;13(1):e81-e97. doi: 10.1016/S2214-109X(24)00409-1.
10
Acellular vaccines for preventing whooping cough in children.用于预防儿童百日咳的无细胞疫苗。
Cochrane Database Syst Rev. 2012 Mar 14(3):CD001478. doi: 10.1002/14651858.CD001478.pub5.

本文引用的文献

1
Rising pertussis cases and deaths in China: current trends and clinical solutions.中国百日咳病例和死亡人数上升:当前趋势和临床解决方案。
Emerg Microbes Infect. 2024 Dec;13(1):2389086. doi: 10.1080/22221751.2024.2389086. Epub 2024 Aug 21.
2
Pertussis vaccination in adults in France: Overview and suggestions for improvement.法国成人百日咳疫苗接种:概述及改进建议。
Infect Dis Now. 2024 Sep;54(6):104961. doi: 10.1016/j.idnow.2024.104961. Epub 2024 Aug 2.
3
Public health management of pertussis in adults: Practical challenges and future strategies.成人百日咳的公共卫生管理:实际挑战与未来策略
Hum Vaccin Immunother. 2024 Dec 31;20(1):2377904. doi: 10.1080/21645515.2024.2377904. Epub 2024 Jul 17.
4
Atypical surge of hospitalized and severe cases of pertussis: A single center 19-years study from China.百日咳住院及重症病例的非典型激增:来自中国的一项单中心19年研究
Pulmonology. 2024 Nov-Dec;30(6):636-638. doi: 10.1016/j.pulmoe.2024.06.006. Epub 2024 Jul 14.
5
Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Strains - Beijing, China, 2022-2023.耐红霉素及缺乏百日咳杆菌黏附素和丝状血凝素菌株的出现——中国北京,2022年至2023年
China CDC Wkly. 2024 May 17;6(20):437-441. doi: 10.46234/ccdcw2024.085.
6
Unraveling the resurgence of pertussis: Insights into epidemiology and global health strategies.解读百日咳的再度流行:对流行病学和全球卫生策略的见解
Pulmonology. 2024 Nov-Dec;30(6):503-505. doi: 10.1016/j.pulmoe.2024.04.009. Epub 2024 May 16.
7
Infections in preschool and school-aged children are driving the recent rise in pertussis in China.学龄前和学龄儿童感染是近期中国百日咳病例增加的原因。
J Infect. 2024 Jun;88(6):106170. doi: 10.1016/j.jinf.2024.106170. Epub 2024 Apr 24.
8
[Clinical characteristics of pertussis in hospitalized children under 3 months].[3个月以下住院儿童百日咳的临床特征]
Zhonghua Yi Xue Za Zhi. 2024 Apr 23;104(16):1422-1425. doi: 10.3760/cma.j.cn112137-20231107-01030.
9
Reduced pertussis disease severity in infants following the introduction of pertussis vaccination of pregnant women in Spain, 2015-2019.2015 - 2019年西班牙孕妇接种百日咳疫苗后婴儿百日咳疾病严重程度降低
Vaccine. 2024 Apr 19;42(11):2810-2816. doi: 10.1016/j.vaccine.2024.03.028. Epub 2024 Mar 25.
10
The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic.在 COVID-19 大流行期间,中国东部地区针对百日咳毒素和丝状血凝素的免疫球蛋白 G 抗体的血清流行病学。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2331438. doi: 10.1080/21645515.2024.2331438. Epub 2024 Mar 22.